{"id":919215,"date":"2025-12-12T08:03:15","date_gmt":"2025-12-12T13:03:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\/"},"modified":"2025-12-12T08:03:15","modified_gmt":"2025-12-12T13:03:15","slug":"nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\/","title":{"rendered":"NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and \u2018FEED\u2019"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and \u2018FEED\u2019<\/b><\/p>\n<p class=\"bwalignc\"><i>New ticker symbol, \u201cFEED\u201d will begin trading on the Nasdaq at the open of the market on December 12, 2025<\/i><\/p>\n<p>TYLER, Texas&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<b>NanoVibronix, Inc. (NASDAQ: NAOV)<\/b> (\u201cNanoVibronix\u201d or the \u201cCompany\u201d), a medical technology company specializing in non-invasive therapeutic systems, today announced that it will change its corporate name from NanoVibronix, Inc. to ENvue Medical, Inc., effective December 12, 2025, to better reflect its new strategic direction and primary focus on its ENvue\u00ae feeding-tube placement system (\u201cENvue\u201d). The Company\u2019s ticker for its common stock, listed on the Nasdaq Capital Market, will also change to \u201cFEED,\u201d which will begin trading under the new symbol beginning with the market open on the same day, December 12, 2025.\n<\/p>\n<p>\n\u201cOur strategy is now focused on scaling hospital utilization, strengthening our commercial footprint and building a comprehensive enteral-feeding ecosystem around ENvue through both internal development and external business development opportunities,\u201d said Doron Besser, M.D., Chief Executive Officer of the Company. \u201cWe believe this rebranding marks a new phase for the Company: one defined by precision enteral access, technology-driven growth and clinical excellence.\u201d\n<\/p>\n<p>\nIn connection with the name change and stock symbol change, no action is required from current stockholders and the Company\u2019s CUSIP number for its common stock will remain the same.\n<\/p>\n<p><b>About NanoVibronix, Inc.<\/b><\/p>\n<p>\nNanoVibronix, Inc. (NASDAQ: NAOV) is a medical technology company advancing both non-invasive and minimally invasive solutions across clinical and home care settings. Headquartered in Tyler, Texas, with research and development in Nesher, Israel, the Company focuses on two distinct technology platforms:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nAcoustic-based therapeutic technologies, including PainShield\u00ae and UroShield\u00ae, which utilize proprietary low-intensity surface acoustic wave (SAW) technology. These devices are intended for use in home or care settings and are designed to treat pain, reduce bacterial colonization, and disrupt biofilms.\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li>\nENvue\u2122 Navigation Platform, developed and operated by ENvue Medical Holdings, Corp., with offices in Arlington Heights, Illinois, and Tel Aviv, Israel, is a minimally invasive electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract. FDA 510(k) cleared for adult use, ENvue provides real-time bedside visualization of tube movement and supports informed decision-making during the placement procedure. Future platform expansion may include pediatric and vascular access applications.\n<\/li>\n<\/ul>\n<p>\nNanoVibronix aims to advance standards in non-invasive therapy and minimally invasive navigation, with a commitment to patient safety, clinical usability, and technology innovation across a range of healthcare environments.\n<\/p>\n<p><b>Forward-Looking Statements<\/b><\/p>\n<p>\nThis press release contains \u201cforward-looking statements.\u201d Such statements may be preceded by the words \u201cintends,\u201d \u201cmay,\u201d \u201cwill,\u201d \u201cplans,\u201d \u201cexpects,\u201d \u201canticipates,\u201d \u201cprojects,\u201d \u201cpredicts,\u201d \u201cestimates,\u201d \u201caims,\u201d \u201cbelieves,\u201d \u201chopes,\u201d \u201cpotential,\u201d or similar words. These forward-looking statements include, but are not limited to: statements regarding the adoption and implementation of ENvue Medical\u2019s platforms, anticipated commercial expansion, growth, scalability and implementation of ENvue Medical\u2019s products, the Company\u2019s proposed name and symbol change, market interest in the Company\u2019s technology, and future expectations for strategic growth. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company\u2019s control and cannot be predicted or quantified; consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation: (i) market acceptance of the Company\u2019s existing and new products; (ii) clinical performance and operational outcomes; (iii) delays or complications in product implementation; (iv) intense competition in the medical device industry; (v) product liability or performance issues; (vi) limitations in manufacturing or supply chain capabilities; (vii) reimbursement limitations; (viii) intellectual property protection; (ix) healthcare regulatory changes in the U.S. and abroad; and (x) the need for additional capital. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company\u2019s filings with the Securities and Exchange Commission (\u201cSEC\u201d), including the Company\u2019s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. Investors and security holders are urged to read these documents free of charge at: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov&amp;esheet=54375092&amp;newsitemid=20251212303918&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=1&amp;md5=b136bd88c68e59f7f92ff9d5ea3f9b1c\">www.sec.gov<\/a>. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events, or otherwise, except as required by law.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251212303918r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20251212303918\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20251212303918\/en\/<\/a><\/span><\/p>\n<p>\nBrett Maas, Managing Principal<br \/>\n<br \/>Hayden IR, LLC<br \/>\n<br \/><span class=\"bwuline\"><a rel=\"nofollow\" href=\"mailto:brett@haydenir.com\">brett@haydenir.com<br \/>\n<\/a><\/span><br \/>(646) 536-7331\n<\/p>\n<p><b>KEYWORDS:<\/b> Texas United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Health Technology Health Medical Devices<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\" \/>\n","protected":false},"excerpt":{"rendered":"<p>NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and \u2018FEED\u2019 New ticker symbol, \u201cFEED\u201d will begin trading on the Nasdaq at the open of the market on December 12, 2025 TYLER, Texas&#8211;(BUSINESS WIRE)&#8211;NanoVibronix, Inc. (NASDAQ: NAOV) (\u201cNanoVibronix\u201d or the \u201cCompany\u201d), a medical technology company specializing in non-invasive therapeutic systems, today announced that it will change its corporate name from NanoVibronix, Inc. to ENvue Medical, Inc., effective December 12, 2025, to better reflect its new strategic direction and primary focus on its ENvue\u00ae feeding-tube placement system (\u201cENvue\u201d). The Company\u2019s ticker for its common stock, listed on the Nasdaq Capital Market, will also change to \u201cFEED,\u201d which will begin trading under the new symbol beginning with the market &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and \u2018FEED\u2019&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-919215","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and \u2018FEED\u2019 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and \u2018FEED\u2019 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and \u2018FEED\u2019 New ticker symbol, \u201cFEED\u201d will begin trading on the Nasdaq at the open of the market on December 12, 2025 TYLER, Texas&#8211;(BUSINESS WIRE)&#8211;NanoVibronix, Inc. (NASDAQ: NAOV) (\u201cNanoVibronix\u201d or the \u201cCompany\u201d), a medical technology company specializing in non-invasive therapeutic systems, today announced that it will change its corporate name from NanoVibronix, Inc. to ENvue Medical, Inc., effective December 12, 2025, to better reflect its new strategic direction and primary focus on its ENvue\u00ae feeding-tube placement system (\u201cENvue\u201d). The Company\u2019s ticker for its common stock, listed on the Nasdaq Capital Market, will also change to \u201cFEED,\u201d which will begin trading under the new symbol beginning with the market &hellip; Continue reading &quot;NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and \u2018FEED\u2019&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-12T13:03:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251212303918r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and \u2018FEED\u2019\",\"datePublished\":\"2025-12-12T13:03:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\\\/\"},\"wordCount\":769,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20251212303918r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\\\/\",\"name\":\"NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and \u2018FEED\u2019 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20251212303918r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2025-12-12T13:03:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20251212303918r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20251212303918r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and \u2018FEED\u2019\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and \u2018FEED\u2019 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\/","og_locale":"en_US","og_type":"article","og_title":"NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and \u2018FEED\u2019 - Market Newsdesk","og_description":"NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and \u2018FEED\u2019 New ticker symbol, \u201cFEED\u201d will begin trading on the Nasdaq at the open of the market on December 12, 2025 TYLER, Texas&#8211;(BUSINESS WIRE)&#8211;NanoVibronix, Inc. (NASDAQ: NAOV) (\u201cNanoVibronix\u201d or the \u201cCompany\u201d), a medical technology company specializing in non-invasive therapeutic systems, today announced that it will change its corporate name from NanoVibronix, Inc. to ENvue Medical, Inc., effective December 12, 2025, to better reflect its new strategic direction and primary focus on its ENvue\u00ae feeding-tube placement system (\u201cENvue\u201d). The Company\u2019s ticker for its common stock, listed on the Nasdaq Capital Market, will also change to \u201cFEED,\u201d which will begin trading under the new symbol beginning with the market &hellip; Continue reading \"NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and \u2018FEED\u2019\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\/","og_site_name":"Market Newsdesk","article_published_time":"2025-12-12T13:03:15+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251212303918r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and \u2018FEED\u2019","datePublished":"2025-12-12T13:03:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\/"},"wordCount":769,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251212303918r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\/","name":"NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and \u2018FEED\u2019 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251212303918r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2025-12-12T13:03:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251212303918r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251212303918r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-medical-inc-and-feed\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and \u2018FEED\u2019"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/919215","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=919215"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/919215\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=919215"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=919215"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=919215"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}